2017年12月21日 · Basic knowledge of types of intravenous ports can help nurses who manage these for patients.

2024年12月12日 · Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative high-risk breast, according to 6-year data from the OlympiA trial.

2024年12月11日 · T-DXd improved PFS, vs treatment of physician’s choice, irrespective of time to progression or type of endocrine resistance among patients with hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer.

2024年10月29日 · “You can control where you focus your attention,” said Anne M. Reb, PhD, NP, who recently presented on a nurse-led intervention for patients who experience fear of cancer recurrence.

2024年9月3日 · Throughout the month of August, several cancer therapies have been approved by the FDA for diseases including non-small cell lung cancer (NSCLC), cutaneous T-cell lymphoma, astrocytoma and oligodendroglioma, and endometrial cancer. Here is a select list of oncology drugs that received FDA approval this past month. First-Line Amivantamab Plus Lazertinib Receives FDA Approval for EGFR-Positive ...

2024年12月18日 · The role of circulating tumor DNA is growing: From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

2024年12月27日 · The FDA approved tislelizumab plus chemotherapy for the first-line treatment of unresectable or metastatic gastric or GEJ adenocarcinoma.

2024年9月23日 · Nurses play a crucial role for patients with prostate cancer undergoing radiation treatment, according to a radiation oncology nurse.

2024年11月12日 · Topical treatments may help ease chemotherapy-induced peripheral neuropathy, but more research is needed.

Key opinion leaders examine approaches to managing skin-related side effects, such as rash, in patients on EGFR inhibitors, highlighting strategies to address quality-of-life impacts while maintaining the benefits of treatment.